Estimating ranibizumab injection numbers and visual acuity at 12 months based on 2-month data on branch retinal vein occlusion treatment

Anti-vascular endothelial growth factor treatment for macular edema secondary to branch retinal vein occlusion generally provides good visual acuity (VA) improvement but may require repeated injections for years. To reduce the number of patients who suffer from avoidable VA loss caused by treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Toshinori, Kondo, Mineo, Inoue, Makoto, Nakao, Shintaro, Osaka, Rie, Shiragami, Chieko, Sogawa, Kenji, Mochizuki, Akikazu, Shiraga, Rumiko, Kaneko, Takeumi, Chandrasekhar, Chikatapu, Tsujikawa, Akitaka, Kamei, Motohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090796/
https://www.ncbi.nlm.nih.gov/pubmed/35538139
http://dx.doi.org/10.1038/s41598-022-11113-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090796/
https://www.ncbi.nlm.nih.gov/pubmed/35538139
http://dx.doi.org/10.1038/s41598-022-11113-y

Ejemplares similares